L.K. Benson & Company, P.C. Abbott Laboratories Transaction History
L.K. Benson & Company, P.C.
- $163 Billion
- Q2 2025
A detailed history of L.K. Benson & Company, P.C. transactions in Abbott Laboratories stock. As of the latest transaction made, L.K. Benson & Company, P.C. holds 2,564 shares of ABT stock, worth $335,704. This represents 0.21% of its overall portfolio holdings.
Number of Shares
2,564
Previous 2,885
11.13%
Holding current value
$335,704
Previous $383 Million
8.88%
% of portfolio
0.21%
Previous 0.27%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,585Shares Held
1.38BCall Options Held
9.73MPut Options Held
8.88M-
Vanguard Group Inc Valley Forge, PA170MShares$22.2 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.2 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.75 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.64 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...